Author Archives: Allon Therapeutics
New Allon research presented at leading scientific symposium
VANCOUVER, B.C. — Allon Therapeutics Inc. (TSX: NPC) announced today that a presentation given May 12 at the prestigious 12th International Stockholm / Springfield Symposium on Advances in Alzheimer Therapy featured new research with Allon’s lead product candidate, davunetide, showing a preventio... Continue reading
Posted in News Releases
Allon Therapeutics releases first quarter 2012 operating results
VANCOUVER, B.C. — Allon Therapeutics Inc. (TSX: NPC) today announced its unaudited operating results for the three months ended March 31, 2012 and updated clinical development plans for 2012. Gordon McCauley, Allon’s President and CEO, said the Company’s most significant achievement during the f... Continue reading
Posted in News Releases
Allon Therapeutics announces completion of $10-million private placement
VANCOUVER, B.C. — Allon Therapeutics Inc. (TSX: NPC) announced today that it has completed the previously announced brokered private placement equity offering resulting in gross proceeds of $10 million as more particularly described below. Gordon McCauley, President and CEO of Allon Therapeutics... Continue reading
Posted in News Releases
Allon Therapeutics announces private placement
VANCOUVER, B.C. — Allon Therapeutics Inc. (TSX: NPC) announced today that it plans to complete a brokered private placement equity offering to raise approximately $10.0 million. The placement is substantially committed. The proceeds will be used for the completion of Allon’s ongoing pivotal clin... Continue reading
Posted in News Releases
Allon granted U.S. patent for neurotoxicity caused by anti-cancer drugs
VANCOUVER, B.C. — Allon Therapeutics Inc. (TSX: NPC) announced today that it has been granted a U.S. patent that covers the use of the Company’s neuroprotective technology platform in the treatment of peripheral neuropathy. This includes the Company’s lead drug candidate, davunetide, and pipeline... Continue reading
Posted in News Releases